🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseMASH prevalence in GLP-1 users — November 2025 Page 8

MASH prevalence in GLP-1 users — November 2025

tampaLisa73 Wed, Jun 4, 2025 at 3:50 AM 44 replies 2,251 viewsPage 8 of 9
LibrarianMeg
Senior Member
1,678
7,890
Mar 2024
Baltimore, MD
Jun 13, 2025 at 6:58 PM#36

From the other side of the consultation, briefly. Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the correction. That is slower than asserting, and it is the only version that survives being wrong.

16 14Dr.NateNeph, PharmD_Rodriguez, julia.endo and 13 others
Reply Quote Save Share Report
FitDadDave
Member
534
2,678
Jul 2024
Minneapolis, MN
Jun 14, 2025 at 5:14 AM#37
LibrarianMeg said:
Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the…

Same pattern here, and in the same order. Posting only so the count is not one.

17 15kim_atl_prep, sarah_TO, wendy_avl and 14 others
Reply Quote Save Share Report
dan_philly
Member
456
2,123
Jul 2024
Philadelphia, PA
Jun 14, 2025 at 3:30 PM#38
LibrarianMeg said:
Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the…

There is a second half to this that has not been said yet. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

Last edited: Jun 14, 2025 at 6:30 PM
18 16SkepticalSean, Dr.CardioMD, EndoResFellow and 15 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
josh_phd_bmore
Member
389
1,678
Jul 2024
Baltimore, MD
Jun 15, 2025 at 1:45 AM#39

Adding the numbers, since they settle part of this. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

Last edited: Jun 15, 2025 at 3:45 AM
19 17KarenAZ_mom, zoe_NC, Dr.ObesityLA and 16 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Jun 15, 2025 at 12:00 PM#40

One thing that is still open after LibrarianMeg’s answer:

Did your prescriber agree with that reading, and if not what was their objection?

Last edited: Jun 15, 2025 at 2:00 PM
41 14PurityPaulOR, MaxMetOK, MounjBrad and 38 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register